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AbstrACt
Introduction Study drop- out and attrition from treating 
clinics is common among persons with chronic health 
conditions. However, if attrition is associated with adverse 
health outcomes, it may bias or mislead inferences for 
health policy and resource allocation.
Methods This retrospective cohort study uses data 
attained through the Swiss Spinal Cord Injury (SwiSCI) 
cohort study on persons with spinal cord injury (SCI). Vital 
status (VS) was ascertained either through clinic medical 
records (MRs) or through municipalities in a secondary 
tracing effort. Flexible parametric survival models were 
used to investigate risk factors for going lost to clinic 
(LTC) and the association of LTC with subsequent risk of 
mortality.
results 1924 individuals were included in the tracing 
study; for 1608 of these cases, contemporary VS was 
initially checked in the MRs. VS was ascertained for 704 
cases of the 1608 cases initially checked in MRs; of the 
remaining cases (n=904), nearly 90% were identified in 
municipalities (n=804). LTC was associated with a nearly 
fourfold higher risk of mortality (HR=3.62; 95% CI 2.18 
to 6.02) among persons with traumatic SCI. Extended 
driving time (ie, less than 30 min compared with 30 min 
and longer to reach the nearest specialised rehabilitation 
facility) was associated with an increased risk of mortality 
(HR=1.51, 95% CI 1.02 to 2.22) for individuals with non- 
traumatic SCI.
Conclusion The differential risk of LTC according 
to sociodemographic and SCI lesion characteristics 
underscores the importance of accounting for attrition in 
cohort studies on chronic disease populations requiring 
long- term care. In addition, given the associated risk of 
mortality, LTC is an issue of concern to clinicians and 
policy makers aiming to optimise the long- term survival of 
community- dwelling individuals with traumatic SCI. Future 
studies are necessary to verify whether it is possible to 
improve survival prospects of individuals LTC through more 
persistent outreach and targeted care.
IntroduCtIon
Clinic attrition—or loss to clinic (LTC), in 
which case individuals experience irregular 
or discontinued care—and study drop- out is 
common among persons with chronic health 
conditions, particularly given the necessitated 
extended follow- up periods to ensure optimal 
health.1 Unfortunately, if an individual’s risk 
of adverse health outcomes is associated with 
irregular or discontinued care, individuals 
who go LTC may subsequently be at a higher 
risk for premature mortality and adverse 
health outcomes. For example, a follow- up 
study on attrition among persons with HIV 
estimated attrition to underestimate 1- year 
mortality by up to 76%.2 An increased propen-
sity for study drop- out or attrition could be 
indicative of individuals LTC being in poorer 
health.1 The opposite is also conceivable, 
with individuals in better health more likely 
to forego scheduled follow- up care. In either 
case, attrition may bias the available informa-
tion with respect to health states and health-
care needs of patients and mislead inferences 
strengths and limitations of this study
 ► An extensive tracing effort was undertaken to ascer-
tain the vital status of all individuals lost to clinic in 
the Swiss rehabilitation setting.
 ► Only three of the five specialised rehabilitation cen-
tres underwent an initial check of medical records 
for updated vital status information.
 ► Sensitivity analyses were employed to ensure that 
systematic differences in tracing methodology 
across specialised rehabilitation centres did not af-
fect conclusions.
 ► It was not possible to include secondary health con-
ditions—a potential unmeasured confounder—in 
the present study.
 ► E- values were estimated to assess the potential in-
fluence of unmeasured confounding on study results 
and conclusions.
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for health policy and resource allocation.3 However, while 
evidence on the influence of clinic attrition on health 
outcomes is available for certain chronic conditions, such 
as HIV or cancer, in the context of physical impairment 
evidence is lacking.
Spinal cord injuries (SCIs) are a chronic health condi-
tion with life- long repercussions on social and health 
outcomes.4 Unfortunately, with the exception of settings 
allowing personalised linkage to a national vital statis-
tics database by common person ID (eg, Norway and 
Australia), most SCI- specific studies have largely ignored 
the issue of attrition in the estimation of mortality and 
survival.5–7 Studies have either not addressed whether 
attrition poses an issue to the interpretation of results; 
not addressed how study attrition was accounted for to 
reduce potential bias in estimates of mortality and survival; 
or only addressed it through a narrative account as part 
of a limitations discussion. The Swiss Spinal Cord Injury 
(SwiSCI) cohort study is a multicentre, longitudinal study 
and a rich resource for studies aimed at improving the 
lives of persons with SCI. However, given that the centres 
from which the initial data are acquired rely on routine 
practice for follow- up (ie, passive follow- up, in which 
centres rely on patients reaching out to inform regarding 
health), SwiSCI- based studies may be at risk for attrition 
bias. To resolve this, an extended effort was undertaken 
to update the database for all study participants without 
a recent vital status by employing a tracing methodology 
used previously in the Swiss context.8 To investigate the 
extent and potential impact of attrition within the SwiSCI 
database, the present study therefore aims to identify 
relevant risk factors for clinic attrition and to evaluate the 
potential differential risk in mortality between those LTC 
compared with those with continued care in Swiss- based 
SCI- specialised rehabilitation centres.
Methods
tracing methodology
The Medical Records study, encompassed within the 
SwiSCI cohort study (described in detail elsewhere), is a 
retrospective cohort study of persons admitted for first 
rehabilitation in Switzerland in one of the five special-
ised rehabilitation centres.9–11 Using the Medical Records 
study as an initial base to identify study participants, 
the community survey was designed to then follow- up 
community- dwelling persons with SCI in Switzerland 
using a prospective panel study design with recurring 
surveys every 5 years.12 In September 2011, the first 
community survey (2012 CS) was sent to potential partic-
ipants. This provided a natural point at which to re- eval-
uate and update the vital status (VS) of many individuals 
identified in the original Medical Records study, based 
on either active participation or active refusal in the 
2012 CS.13 For individuals who did not actively respond 
to the 2012 CS, or for whom no recent contact (ie, post- 
September 2011) was made with the study centre, VS was 
manually updated through a secondary tracing study 
(figure 1). Briefly, medical records were first checked 
in specialised rehabilitation centres to determine the 
last date of contact with the clinic. If an individual had 
visited the clinic on or after 30 September 2011, they were 
considered alive with vital status ascertained in clinic and 
thereby not lost to clinic. If an individual did not have a 
recent clinic contact, the municipality of their last known 
address was contacted with a request for information on 
the VS of the individual. If vital status could be ascertained 
from municipality records, individuals were considered 
LTC but not lost to follow- up (LTFU) (note: individuals 
were only considered LTC if medical records were first 
checked for VS). Finally, if VS could not be ascertained 
from municipality records, only then were individuals 
considered LTFU. The Childhood Cancer Registry previ-
ously employed a similar methodology in Switzerland.8 
Given the integral role of the 2012 CS for ascertaining 
VS, 30 September 2011 marks the cut- off date for the 
present study. To ensure adequate data quality, the study 
was further restricted to individuals who started first 
rehabilitation from 1990 onwards, when two specialized 
rehabilitation facilities were opened. Ascertainment of 
pre-1990 cases was frequently incomplete, partly related 
to the between- clinic transfer or even destruction of MRs 
on closure of a historical facility.
From 1990 to 2007, there was no official, opera-
tional guideline for the long- term follow- up care of 
persons living with SCI in Switzerland. However, there 
was a consensus among physicians in specialised SCI 
centres that all persons needed regular follow- up visits 
at 3 months, 6 months, 1 year and then annually. Since 
2007, this follow- up scheme has been endorsed as formal 
guideline by the Swiss Society of Paraplegia and imple-
mented by all clinics for specialised SCI care in Switzer-
land.14 Patients who do not respond to the invitation for 
a follow- up visit are reminded at least once (by written 
letter or telephone call) and asked to contact the clinic. 
Unfortunately, no formal and comprehensive evaluation 
exists regarding the practical implementation and effec-
tiveness of follow- up procedures.
descriptive statistics
For categorical variables, descriptive analyses consisted of 
crude numbers and percentages; for continuous variables 
the mean, median, SD and range are reported. Descrip-
tive analyses of non- traumatic SCI (NTSCI) and traumatic 
SCI (TSCI) are reported stratified by key demographic 
characteristics and SCI- specific characteristics (ie, strati-
fied by sex, age, lesion level, lesion completeness or time 
period since injury).15 Non- parametric or parametric tests, 
depending on the distribution, were used to compare 
group characteristics. Only individuals who were followed 
up initially through the clinic were included in analyses 
(n=1608); individuals for which no initial VS identifica-
tion was attempted through clinic medical records were 
not included in analyses (n=285). Individuals considered 
completely LTFU were excluded from the analysis of LTC- 
associated risk for premature mortality (n=100).
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Figure 1 Tracing methodology for vital status ascertainment. ‘VS update from other source (n=31)’ includes individuals 
included within the VS update tracing study but for whom the VS was ascertained from individuals’ response to contact by the 
SwiSCI study centre. SwiSCI, Swiss Spinal Cord Injury cohort study; VS, vital status.
risk factors for LtC
Individuals were considered LTC (yes/no) if their 
last clinic contact was 18 months or more before the 
population censoring date of the study (30 September 
2011). The dichotomous LTC variable was then used 
as the outcome of interest in a flexible parametric 
(FP) survival model, for which time- at- risk started with 
discharge from specialised rehabilitation including an 
18- month buffer, and then ended either at the popula-
tion censoring date (ie, study end – 30 September 2011) 
or when patients were identified as LTC.16 The 18- month 
buffer was chosen based on: (A) clinical recommenda-
tions for regular, yearly (12–18 months) follow- up outpa-
tient visits and (B) methodological recommendations 
by Lesko et al17 to censor at date of study- specific LTFU 
definition, rather than date of last contact given that 
the event of interest (mortality) is captured outside of a 
study encounter. Risk factors for going LTC included in 
the model were: driving distance to first rehabilitation 
clinic (driving time of <30 min or driving time of 30 min 
or more); age at injury; sex; lesion level and complete-
ness of lesion; discharge destination; and specialised 
rehabilitation clinic attended. Confounders were identi-
fied using directed acyclic graphs (DAGs) informed by 
theory, previous evidence and data availability (online 
supplementary figure 1).18 The calculation of driving 
distance mimicked calculations previously carried out 
in the Swiss context, with distance to clinic measured as 
driving time from last known address to specialised reha-
bilitation clinic; this was calculated using road network 
information available from TomTom MultiNet shapefiles 
(2011) and ArcGIS Network Analyst.19 Hospital addresses 
were identified using data from the Swiss Federal Statis-
tics Office and Federal Office of Topography (swisstopo), 
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with coordinates derived using geocoding tools avail-
able within the ArcGIS 10.3 suite. Driving duration was 
estimated in minutes to destination. Driving time to the 
closest specialised rehabilitation clinic was dichotomised 
(ie, less than 30 min driving time vs 30 min or more 
driving time). Analyses were stratified according to aeti-
ology of SCI (ie, TSCI or NTSCI). To ensure robustness of 
risk factor identification, in sensitivity analyses, multiple 
imputation (MI) using chained equations was used to fill 
in missing information for completeness of lesion (n=89) 
– using Rubin’s rules for derivation of global point esti-
mates and confidence intervals from 20 imputations.20 
Bootstrapping (using 1000 replications) was further 
used to account for potential chance effects due to small 
sample size.
Influence of LtC on risk of mortality
An FP survival model was employed to determine the 
influence of LTC on risk of premature mortality.16 For 
this analysis, time- at- risk started with discharge from 
specialised rehabilitation (including an 18- month 
buffer window) and ended with death or administrative 
censoring due to study end. Given the likely differential 
force of mortality attributable to ageing with a spinal cord 
injury, attained age (ie, age at death or study end) was 
used in place of age at injury.21 For those LTC, time- at- risk 
was partitioned according to pre- LTC and post- LTC based 
on date of last clinic contact using splitting techniques. 
This allows for the follow- up time contribution to sepa-
rate risk sets (ie, time when not LTC and time when LTC) 
and subsequent calculation of corresponding HRs of risk 
for mortality (online supplementary figure 2). Similar 
to the aforementioned analysis, confounders were iden-
tified using DAGs (online supplementary figure 3). For 
multilevel categories, post hoc testing was used to eval-
uate support for between- level differences. In order to 
account for potential centre effects, the cluster option—
cluster ()—was specified. E- values and associated lower 
confidence intervals (LCIs) were calculated to assess the 
robustness of effect estimates in the presence of unmea-
sured confounding.22 Briefly, large E- values would indi-
cate that the unmeasured confounding required would 
need to be considerable to explain away observed asso-
ciate. Importantly, small E- values do not demonstrate that 
no effect exists, only that a weak unmeasured confounder 
could explain away observed association.23
All analyses were conducted using Stata V.14.2 for 
Windows.
Patient and public involvement
Any study undertaken using data collected within the 
context of the SwiSCI cohort study must be first approved 
by members of the SwiSCI Steering Committee. This 
committee includes community representatives who are 
provided the opportunity to give feedback on the study 
design and outcomes. Therefore, although this research 
project did not directly involve patients or the public in 
the analysis and interpretation of results, a committee 
including patient representatives approved the database 
and initial study design.
resuLts
descriptive statistics
Within the SwiSCI Medical Records study, 2920 individ-
uals were injured or suffered a SCI between 1990 and 30 
September 2011 and required updated information on 
their VS. Of these individuals, VS was initially checked in 
the clinic for 83.4% (n=1608) (figure 1). In 43.8% of these 
cases (n=704), contemporary VS information was ascer-
tained through clinic records. Of those individuals for 
which contemporary VS was not ascertained from clinic 
records (n=904), nearly 90% (n=804) were identified 
in municipalities (figure 1). VS was ascertained for 86% 
(n=246) of the cases that were checked directly through 
municipality centres (n=285) (figure 1). Individuals were 
considered LTFU if VS could not be ascertained from 
medical records and/or through municipalities (n=139) 
(figure 1). Given the observed differences in study partic-
ipant characteristics according to SCI aetiology—that is, 
NTSCI or TSCI—all analyses were stratified according to 
SCI aetiology (table 1).
risk factors for clinic attrition
Risk factors associated with going LTC differed across 
SCI aetiologies (table 2). Persons with an attained TSCI 
contributed to a total follow- up time of 4700.6 years 
(average=5.8 years), while persons with NTSCI contrib-
uted a total follow- up time of 1648.4 person- years 
(average=3.3 years). Among persons with TSCI, younger 
ages were associated with a lower risk of LTC, with a more 
than twofold reduction in risk for younger individuals 
between 16 and 30 years of age (HR=0.44; 95% CI 0.31 to 
0.64) and 31 and 45 years of age (HR=0.46; 95% CI 0.32 
to 0.67) in comparison with 61–75 year olds (table 2). 
Complete lesions in persons with TSCI were associated 
with a nearly 40% reduction in risk of going lost to clinic 
(HR=0.73; 95% CI 0.55 to 0.98). No difference in risk was 
observed according to lesion level (table 2). In the group 
of persons with TSCI, a tendency for a reduction in risk of 
nearly 30% was observed for more recent injuries versus 
injuries incurred between 1990 and 1999 (HR=0.79; 95% 
CI 0.60 to 1.03); this remained stable in sensitivity anal-
yses of MI and bootstrapped results. Extended driving 
time to the clinic of first rehabilitation was associated with 
an increase in risk of LTC for both persons with TSCI and 
NTSCI (HR=1.39; 95% CI 1.06 to 1.81 and HR=1.59; 95% 
CI 1.12 to 2.26, respectively) (table 2).
LtC as a risk factor for premature mortality
A total of 1507 cases contributed to 10 827.7 person- 
years at risk (average=7.2 years), with 7727.2 person- 
years attributed to persons with TSCI (average=8.6 
years; deaths=103), and 3.100.5 person- years to persons 
with NTSCI (average=5.1 years; deaths=160). After 
controlling for current age, lesion level, completeness 
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Length of stay in 
months; mean (SD)
5.3 (5.4) 3.2 (2.4) <0.001
Sex (2) <0.001
  Male 799 (71.1) 442 (56.7)
  Female 325 (28.9) 335 (43.0)
Age at injury (12) <0.001
  16–30 360 (32.0)   43 (5.5)
  31–45 272 (24.2) 145 (18.6)
  46–60 222 (19.8) 184 (23.6)
  61–75 174 (15.5) 261 (33.5)
  76+   88 (7.8) 142 (18.2)
Aetiology (8) N.A.
  Transport 316 (28.1) –
  Sports and leisure 223 (19.9) –
  Falls 444 (39.5) –
  Other – TSCI 140 (12.5) –
  Tumour – 202 (26.2)
  Inflammation –   26 (3.4)
  Bleeding –   45 (5.8)
  Infection –   37 (4.8)
  Other – NTSCI – 462 (59.8)
Level of SCI (13) <0.001
  Tetra 614 (55.0) 456 (59.0)
  Para 415 (37.2) 217 (28.1)
  Cauda equina   88 (7.9) 100 (12.9)
Completeness (110) <0.001
  Incomplete 795 (74.6) 670 (92.2)
  Complete 271 (25.4)   57 (7.8)
Lesion level and completeness 
(267)
<0.001
  Paraplegia, 
incomplete
382 (38.4) 388 (60.5)
  Paraplegia, 
complete
215 (21.6)   44 (6.7)
  Tetraplegia, 
incomplete
343 (34.5) 202 (31.5)
  Tetraplegia, 
complete
  55 (5.5)   7 (1.1)
ASIA score (677) <0.001
  AIS A 168 (24.6)   36 (6.6)
  AIS B   66 (9.6)   49 (9.0)
  AIS C 120 (17.7) 105 (19.3)
  AIS D/E 329 (48.1) 353 (65.0)










  C1- C4 ABC   45 (8.5)   11 (2.4)
  C5- C8 ABC   24 (4.5)   14 (3.0)
  T1- S3 ABC 132 (24.9)   86 (18.5)
  AIS D/E 329 (62.1) 353 (76.1)
Destination after discharge (77) 0.10
  Private residence 844 (75.1) 570 (75.3)
  Hospital   86 (7.6)   75 (9.9)
  Nursing home/
assisted living
128 (11.4) 107 (13.8)
  Other (eg, hotel)   12 (1.2)   4 (0.5)
  Death   0 (0.0)   1 (0.1)
Ventilator assistance (16) 0.52
  No 1098 (98.5) 763 (98.8)
  Yes   17 (1.5)   9 (1.2)
Twenty- one individuals missing information on SCI aetiology.
AIS, ASIA Impairement Scale; ASIA, American Spinal Injury 
Association; NTSCI, non- traumatic spinal cord injury; SCI, spinal 
cord injury; TSCI, traumatic spinal cord injury.
Table 1 Continued
and sex, LTC was associated with an increased risk of 
mortality (HR=3.62; 95% CI 2.18 to 6.02) for persons 
with TSCI (figure 2), corresponding to an E- value of 6.70 
(LCI=3.78). This association remained when including 
MI data (HR=3.07; 95% CI 2.29 to 4.13), as well as when 
using bootstrapping (HR=3.59; 95% CI 2.16 to 6.00). 
In comparison with TSCI, no association between LTC 
and risk of mortality was evident for persons with NTSCI 
(E- value=1.88; LCI=1.00). Sensitivity analyses using MI or 
bootstrapping gave similar results. In a secondary analysis 
investigating distance to rehabilitation as a risk factor for 
mortality, there was no evidence to suggest any association 
for persons with TSCI (HR=1.34, 95% CI 0.76 to 2.37). 
However, for persons with NTSCI, a heightened risk of 
mortality was observed for those living 30 min or further 
from specialised rehabilitation (HR=1.51, 95% CI 1.02 to 
2.22), corresponding to an E- value of 2.39 (LCI=1.16).
dIsCussIon
summary
This is the first study to our knowledge that has inves-
tigated LTC in the context of spinal cord injury, and 
the first to investigate the consequences of LTC in the 
broader Swiss setting. The key insight emerging from 
this study is that LTC in persons living with TSCI may 
be indicative of an elevated risk of death. Characteris-
tics of persons with TSCI who are at higher risk to go 
LTC include: older age at injury, incomplete lesion, 
discharge destination to hospital and a driving time 
of more than 30 minutes to specialised rehabilitation 
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  Male Reference Reference
  Female 1.00 (0.77 to 1.30) 1.45 (1.08 to 1.94)
Age at injury (years)
  16–30 0.44 (0.31 to 0.64) 0.95 (0.50 to 1.82)
  31–45 0.46 (0.32 to 0.67) 0.43 (0.26 to 0.70)
  46–60 0.51 (0.35 to 0.76) 0.71 (0.48 to 1.03)
  61–75 Reference Reference
  ≥76 1.62 (1.02 to 2.58) 1.34 (0.90 to 2.01)
Decade
  1990–1999 Reference Reference
  2000–2011 0.79 (0.60 to 1.03) 1.26 (0.88 to 1.81)
Lesion level
  Paraplegia Reference Reference
  Tetraplegia 0.98 (0.76 to 1.27) 0.96 (0.71 to 1.31)
Lesion completeness
  Incomplete Reference Reference
  Complete 0.73 (0.55 to 0.98) 0.98 (0.49 to 1.97)
Distance to first rehabilitation clinic
  <30 min Reference Reference
  >30 min 1.39 (1.06 to 1.81) 1.59 (1.12 to 2.26)
Rehabilitation centre
  A Reference Reference
  B 1.44 (0.98 to 2.10) 1.38 (0.86 to 2.20)
  C 1.36 (0.98 to 1.90) 1.14 (0.79 to 1.64)
  D 3.89 (2.58 to 5.85) 0.96 (0.28 to 3.21)
Discharge destination
  Home Reference Reference




1.12 (0.78 to 1.61) 1.43 (0.94 to 2.19)
  Other 1.50 (0.55 to 4.08) 2.51 (0.34 to 18.40)
Names of rehabilitation facilities (A, B, C and D) refer to the four 
specialised rehabilitation centres within Switzerland with eligible 
data for the present study. Twenty- one cases excluded due to 
missing information on SCI aetiology.
NTSCI, non- traumatic spinal cord injury; SCI, spinal cord injury; 
TSCI, traumatic spinal cord injury.
Figure 2 Risk of mortality based on lost to clinic (LTC) 
status. Grey- filled circles represent the reference group, 
‘not LTC’, while black- filled circles indicate the HR for those 
‘LTC’. Semifilled circles represent HRs based on multiple 
imputation. Vertical black lines correspond to estimated 95% 
CIs. NTSCI, traumatic spinal cord injury; TSCI, traumatic 
spinal cord injury.
clinic. In addition, for individuals with TSCI, going lost 
to clinic was associated with a nearly fourfold higher risk 
of mortality. For individuals with an attained NTSCI, 
only gender and driving time to specialised rehabili-
tation influenced risk of LTC. However, in contrast to 
TSCI, driving time was associated with a higher risk of 
mortality for persons with NTSCI.
Importance of continuity of care
Spinal cord injury is a chronic and serious medical condi-
tion that can result in severe physical and mental disor-
ders often requiring specialised acute and follow- up care. 
A recent survey on morbidity in the Swiss SCI commu-
nity showed that individuals had on average seven 
concomitant health conditions or symptoms.24 The most 
commonly reported physical problems included chronic 
pain, spasticity, sexual dysfunction, bowel dysfunction, 
bladder dysfunction, urinary tract infection and sleep 
problems, with 3- month prevalence ranging between 
74% and 59%.24 In addition, prevalence of depression 
was estimated at 15%.24 While most of these health issues 
emerge on or shortly after injury, they can also develop in 
the months following or up to 1 year post- injury. Accord-
ingly, SCI has been associated with substantially elevated 
all- cause and cause- specific mortality, including mortality 
due to cardiac or ischaemic heart disease, septicaemia, 
specific infections (eg, urinary tract or respiratory infec-
tion) and suicide.13 25 These findings underscore the 
importance of regular, life- long follow- up as part of 
specialised medical care to facilitate early diagnosis and 
effective prevention and treatment of health issues.
Given the complex and chronic nature of spinal cord inju-
ries, a plausible mechanism driving the elevated mortality 
in persons LTC could be discontinuity of care, with LTC 
being indicative of discontinued care. Supporting this, 
previous research has found that improved continuity of 
care is associated with lower mortality rates and improved 
health outcomes.26–28 Although few SCI- specific studies 
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have investigated continuity of care on health outcomes, 
one contemporary study found that persons with conti-
nuity of care were less likely to partake in polyphar-
macy.29 30 To this effect, to improve survival outcomes, 
regular, life- long specialised care is critical for the long- 
term management of secondary health conditions (eg, 
cardiovascular disease, urinary tract infections, respiratory 
infections and pressure ulcers) associated with premature 
mortality.13 However, current evidence suggests inad-
equate management and support of secondary health 
conditions. For example, a 2012 study by Guilcher et al 
31 found that of the emergency department (ED) visits 
by persons with SCI, nearly 20% were potentially prevent-
able and roughly three quarters of those visits were due to 
SCI- specific conditions such as urinary tract infections or 
pneumonia. Although the reason behind ED usage as a 
primary care facility is unknown, it may be due to limited 
access to specialised services given that rurality has been 
associated with higher ED usage.31 32
In a recent study that investigated satisfaction in care for 
persons living with SCI in the Swiss community, individuals 
were found to be less satisfied with availability, quality and 
fulfilment of care and care needs with increased distance 
from specialised rehabilitation centres.33 In this study, 
among individuals with TSCI, driving time to specialised 
rehabilitation was associated with LTC, although not 
the subsequent risk of premature mortality. A potential 
explanation for this could be that LTC mediates the asso-
ciation between driving time and premature mortality, 
which would suggest that it is not access in general that 
influences mortality outcomes and other adverse health 
outcomes, but rather access and continued care in special-
ised rehabilitation facilities. In support of this, previous 
chronic disease and other SCI- specific literature similarly 
points towards the positive influence of specialised reha-
bilitation on health outcomes.34–36 However, in contrast 
to TSCI, no association was found for individuals with an 
attained NTSCI between LTC and mortality, although 
there was an apparent association between driving time 
and subsequent risk of mortality. This could be indicative 
of potentially differing patterns of healthcare utilisation 
due to the impact of ageing with a SCI and subsequent 
requirements for long- term continuation of care. It is also 
important to note that no evidence exists that provides a 
concrete comparison as to whether LTC from a specialised 
rehabilitation centre is more important than LTC from 
generalised care, such as a family physician. Research 
addressing the added value of specialised rehabilitation 
in improving consequences of LTC is thus needed.
Unfortunately, causal inference on the relevancy of 
discontinuity of care with respect to mortality is limited 
due to lack of direct, critical evidence regarding the 
extent to which improved continuity of care may improve 
health outcomes and mortality. Thus, while observational 
studies are important, and often the only ethical solu-
tion, for contributing to evidence- based decisions and 
causal inference, given the secondary, post- study design 
nature of the present study, results from this study may 
be subject to unmeasured confounding factors that affect 
both clinic attendance and secondary health condi-
tions/morbidity.37 For example, secondary health condi-
tions may influence an individual’s propensity towards 
continued care—including the type of clinic visited (ie, 
specialised vs not specialised)—as well as an individual’s 
risk of mortality.38 However, the E- value estimated in this 
study for persons with TSCI demonstrates that to explain 
away the observed association between LTC and risk of 
mortality, the unmeasured confounder would need to 
be associated with both LTC and risk of mortality by a 
nearly sevenfold risk ratio. Nevertheless, for causal infer-
ence pertaining to the role of LTC on subsequent risk 
of mortality, intervention studies designed to specifically 
target this research question and sufficiently account for 
potential confounders are needed, particularly given the 
weak evidence for persons with NTSCI.
Methodological aspect
This study draws attention to the use of routine follow- up 
data in evaluating survival and life expectancy in people 
living with a chronic, physical impairment such as 
spinal cord injury. Similar to findings in other contexts, 
such as HIV or cancer, incomplete ascertainment of VS 
commonly induces underestimation of mortality given 
that individuals with a higher propensity for premature 
mortality are more likely to go LTC.2 39 Furthermore, it is 
very likely that those completely LTFU (ie, no vital status 
information could be ascertained) have an elevated risk 
of mortality. The tracing methodology presented in this 
study provides a feasible approach for garnering addi-
tional information on LTC patterns and the associated 
risk of mortality; VS could also be obtained through 
linkage with national death registries, if available.40 Such 
information can be used to inform future analyses aimed 
at attenuating the potential bias on estimates of mortality 
or other clinical outcomes, for example, through sensi-
tivity analysis, inverse probability weighting, MI or pattern 
mixture modelling.2 40
study limitations
The data used for this study include augmented informa-
tion from a follow- up study meant to ascertain detailed 
vital status information, including date of death, and for 
some cases date of last clinic contact. However, when 
identifying date of last clinic contact, only the original 
specialised rehabilitation clinic was checked; that is, we 
did not cross- reference cases between clinics. Nonethe-
less, switching between specialised rehabilitation institu-
tions for follow- up care is relatively rare and unlikely to 
account for differential mortality related to LTC. Addi-
tionally, during the tracing effort, in the situation that a 
new address was identified, databases were updated; thus, 
the contemporary address was used for all distance calcu-
lations. Another potential limitation is that to be eligible 
for analyses, it was required that VS first be checked in 
medical records. Given that clinic records were checked 
systematically in only three of the specialised rehab 
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clinics, there is a potential for unmeasured confounding 
between patient variables and risk of LTC, which could 
subsequently affect the association between LTC and risk 
of mortality. However, exclusion of specialised rehabili-
tation clinics that did not undergo a systematic check 
of medical records—apart from decade, which was 
no longer associated with risk of LTC—did not modify 
overall conclusions. In addition to this, as mentioned 
above, another potential, unmeasured confounder are 
secondary health conditions. Unfortunately, informa-
tion on secondary health conditions was not collected in 
the SwiSCI Medical Records. However, E- value estimates 
demonstrate that such an unmeasured confounder would 
need to be very strongly associated with both the exposure 
and outcome in order to completely obviate the observed 
association. Finally, the SwiSCI study only includes individ-
uals admitted to one of the SCI- specialised rehabilitation 
centres in Switzerland; differences between patient popu-
lations have been evidenced; therefore, these results may 
not be generalisable to the entire Swiss SCI population.10
Due to data limitations, it was not possible to provide an 
estimate of the underestimation of, for example, 1- year 
mortality; such an estimate would require mortality infor-
mation on individuals LTFU. In the study by Brinkhof et 
al,2 authors used a pattern- mixture model to impute the 
missing survival times for individuals LTFU. Future anal-
yses using the SwiSCI data could use a similar approach 
to account for such survival bias. However, given that 
unmanaged or ineffectively treated HIV infection nearly 
always leads to certain death, the natural force of mortality 
in SCI is considerably less. We would therefore expect a 
much lower relative increase in mortality if including SCI 
patients LTFU.
Conclusion
The present study provides evidence that going LTC is 
associated with poorer survival prospects among indi-
viduals with TSCI. Patterns of LTC may help illuminate 
risk factors for attrition from specialised care and conse-
quently aid in identifying higher risk groups requiring 
targeted care to improve health outcomes and reduce 
premature mortality.5 However, further research is 
needed to determine whether improving continuation 
of care in specialised rehabilitation centres will lead to 
better health outcomes.
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